| Item Type | Name |
|
Academic Article
|
Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.
|
|
Academic Article
|
Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.
|
|
Academic Article
|
Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells.
|
|
Academic Article
|
Toll-like receptors in tumor immunotherapy.
|
|
Academic Article
|
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
|
|
Academic Article
|
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.
|
|
Academic Article
|
The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
|
|
Academic Article
|
Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.
|
|
Academic Article
|
Type 17 CD8+ T cells display enhanced antitumor immunity.
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Cytokines
|
|
Concept
|
Immunologic Factors
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Receptors, NK Cell Lectin-Like
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Precision Medicine
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Lysophospholipids
|
|
Concept
|
Interferon-gamma
|
|
Concept
|
Interleukin-2 Receptor alpha Subunit
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Immunity, Cellular
|
|
Concept
|
Lymphoid Enhancer-Binding Factor 1
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Circadian Rhythm
|
|
Concept
|
Inositol 1,4,5-Trisphosphate Receptors
|
|
Concept
|
KB Cells
|
|
Concept
|
Sphingolipids
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Oncogenes
|
|
Concept
|
Macaca fascicularis
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Genes, MHC Class II
|
|
Concept
|
Lentivirus
|
|
Concept
|
Arthritis, Experimental
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Interleukin-15
|
|
Concept
|
Lysosomal-Associated Membrane Protein 1
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Ceramides
|
|
Concept
|
Dipeptidyl Peptidase 4
|
|
Concept
|
Receptors, Cell Surface
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Isoquinolines
|
|
Concept
|
Electroporation
|
|
Concept
|
Injections
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Receptors, Interferon
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Toll-Like Receptors
|
|
Concept
|
History, 21st Century
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Macrophages
|
|
Concept
|
Rats, Inbred Lew
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Research Design
|
|
Concept
|
Dogs
|
|
Concept
|
Animals
|
|
Concept
|
Leukemia L1210
|
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Tumor Necrosis Factor Receptor Superfamily, Member 7
|
|
Concept
|
Disease Susceptibility
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Polylysine
|
|
Concept
|
ADP-ribosyl Cyclase 1
|
|
Concept
|
Receptors, G-Protein-Coupled
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Antibodies
|
|
Concept
|
Oxidative Phosphorylation
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Immunotherapy, Active
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Mice, Inbred C3H
|
|
Concept
|
Calcium
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Toll-Like Receptor 4
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Lipopolysaccharides
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Disease Management
|
|
Concept
|
L-Selectin
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Hyaluronan Receptors
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Concept
|
Infusions, Intravenous
|
|
Concept
|
Head and Neck Neoplasms
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Bile Duct Neoplasms
|
|
Concept
|
Interleukin-5
|
|
Concept
|
Mice
|
|
Concept
|
Models, Biological
|
|
Concept
|
Leukocyte Common Antigens
|
|
Concept
|
Linear Models
|
|
Concept
|
Immunomodulation
|
|
Concept
|
Microscopy, Confocal
|
|
Concept
|
Proto-Oncogene Proteins c-maf
|
|
Concept
|
Cytokine-Induced Killer Cells
|
|
Concept
|
Melanoma
|
|
Concept
|
Antibodies, Bispecific
|
|
Concept
|
Eye
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Proto-Oncogene Proteins c-kit
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
CD3 Complex
|
|
Concept
|
Interleukin-7
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Melanoma, Experimental
|
|
Concept
|
Interleukins
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Cell Separation
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Simvastatin
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Free Radical Scavengers
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Lovastatin
|
|
Concept
|
Mesothelioma
|
|
Concept
|
Survival Rate
|
|
Concept
|
Humans
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
Jurkat Cells
|
|
Concept
|
Cell Movement
|
|
Concept
|
Biliary Tract Neoplasms
|
|
Concept
|
Complement Inactivating Agents
|
|
Concept
|
beta Catenin
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Pilot Projects
|
|
Concept
|
CpG Islands
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Sphingosine N-Acyltransferase
|
|
Concept
|
Polymyxin B
|
|
Concept
|
Haptens
|
|
Concept
|
Proto-Oncogene Proteins c-sis
|
|
Concept
|
Sirtuin 1
|
|
Concept
|
Hepatocyte Nuclear Factor 1-alpha
|
|
Concept
|
Pentetic Acid
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Receptors, Interleukin-7
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Folic Acid Deficiency
|
|
Concept
|
Major Histocompatibility Complex
|
|
Concept
|
Adoptive Transfer
|
|
Concept
|
Inflammation
|
|
Concept
|
Glycogen Synthase Kinase 3
|
|
Concept
|
Mice, Inbred NOD
|
|
Concept
|
Vascular Endothelial Growth Factor Receptor-3
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Propensity Score
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Intestines
|
|
Concept
|
Chemokine CCL5
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
Arthritis, Rheumatoid
|
|
Concept
|
Receptor, Anaphylatoxin C5a
|
|
Concept
|
Lipopolysaccharide Receptors
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Models, Animal
|
|
Concept
|
Thymus Gland
|
|
Concept
|
Interleukin-1beta
|
|
Concept
|
Immune Evasion
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Cyclosporine
|
|
Concept
|
Lymphocyte Depletion
|
|
Concept
|
Autoantigens
|
|
Concept
|
Antirheumatic Agents
|
|
Concept
|
Immunotherapy, Adoptive
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Medicare
|
|
Concept
|
Immunoconjugates
|
|
Concept
|
K562 Cells
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Receptors, Lysosphingolipid
|
|
Concept
|
Carcinoma, Squamous Cell
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Interleukin Receptor Common gamma Subunit
|
|
Concept
|
Poly I-C
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Wnt Proteins
|
|
Concept
|
Rats
|
|
Concept
|
Chelating Agents
|
|
Concept
|
PPAR gamma
|
|
Concept
|
Reperfusion Injury
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Benzoxazines
|
|
Concept
|
Spleen
|
|
Concept
|
Oligodeoxyribonucleotides
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Mouth Neoplasms
|
|
Concept
|
Apyrase
|
|
Concept
|
Models, Molecular
|
|
Concept
|
Interleukin-12
|
|
Concept
|
5'-Nucleotidase
|
|
Concept
|
Receptors, CCR7
|
|
Concept
|
Graft Survival
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Rats, Sprague-Dawley
|
|
Concept
|
Proteasome Endopeptidase Complex
|
|
Concept
|
United States
|
|
Concept
|
Antigens, CD19
|
|
Concept
|
Vaccination
|
|
Concept
|
Technetium
|
|
Concept
|
Mice, Inbred DBA
|
|
Concept
|
Skin Neoplasms
|
|
Concept
|
Complement C3
|
|
Concept
|
Chemokines
|
|
Concept
|
CD28 Antigens
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily B
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Arthritis
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Colonic Neoplasms
|
|
Concept
|
Immune Tolerance
|
|
Concept
|
Italy
|
|
Concept
|
Immunologic Memory
|
|
Concept
|
Genes, MHC Class I
|
|
Concept
|
Microsatellite Instability
|
|
Academic Article
|
Reducing CD73 expression by IL1?-Programmed Th17 cells improves immunotherapeutic control of tumors.
|
|
Academic Article
|
Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8(+) T cells.
|
|
Academic Article
|
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.
|
|
Academic Article
|
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells.
|
|
Academic Article
|
Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis.
|
|
Academic Article
|
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic.
|
|
Academic Article
|
Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function.
|
|
Academic Article
|
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
|
|
Academic Article
|
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8+ T cells.
|
|
Concept
|
gp100 Melanoma Antigen
|
|
Concept
|
MART-1 Antigen
|
|
Concept
|
Folate Receptors, GPI-Anchored
|
|
Concept
|
Folate Receptor 2
|
|
Concept
|
Th17 Cells
|
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
|
Concept
|
Class Ib Phosphatidylinositol 3-Kinase
|
|
Concept
|
GPI-Linked Proteins
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Inducible T-Cell Co-Stimulator Protein
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Microbiota
|
|
Concept
|
Liquid Biopsy
|
|
Concept
|
Gastrointestinal Microbiome
|
|
Concept
|
Glycogen Synthase Kinase 3 beta
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Ipilimumab
|
|
Concept
|
Placenta Growth Factor
|
|
Concept
|
Hepatitis A Virus Cellular Receptor 2
|
|
Academic Article
|
Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-? (ROR?) Agonist for Use in Treating Cancer.
|